Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.88 BRL | +1.07% | -2.72% | +5.86% |
Mar. 12 | Cosmetics group Natura's shares rise with higher margin, dividends even as loss widens | RE |
Mar. 12 | Transcript : Natura &Co Holding S.A., Q4 2023 Earnings Call, Mar 12, 2024 |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.88 for the current period. Therefore, the company is undervalued.
- The company appears to be poorly valued given its net asset value.
- The company has a low valuation given the cash flows generated by its activity.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- With an expected P/E ratio at 39.73 and 15.63 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+5.86% | 4.94B | B+ | ||
-2.66% | 253B | B- | ||
-2.98% | 17.38B | B+ | ||
-3.53% | 10.91B | A- | ||
-3.70% | 10.71B | A- | ||
-16.41% | 5.53B | B+ | ||
-6.14% | 5.12B | B | ||
+3.57% | 3.89B | B- | ||
-12.75% | 3.49B | C+ | ||
-24.91% | 3.05B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock
- Equities
- Stock Natura &Co Holding S.A. - Sao Paulo
- Ratings Natura &Co Holding S.A.